Crescent Biopharma, Inc.
- CBIO
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Bispecific Antibodies
$11.84
Today −5.13%Quote Oct 16, 2026, 08:00 PM UTC
−29.40%over the last month
Max drawdown −29.9%From 1-month high −29.9%3 months −21.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$439.8M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$36.00
+204.1% from here
Floor
$11.54
2.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
44